SWHR Statement on Dr. Robert Califf Appointment Posted on February 15, 2022 by Lindsey Horan - Blog Post, Statement
The Complementary Nature of Federal Science Agencies in Advancing the Nation’s Health Posted on October 4, 2021 by Lindsey Horan - Blog Post
Most Common Liver Disease in America Affects Women and Men Differently Posted on June 1, 2021 by Dezimey Kum - Blog Post
Exploring Opportunities to Engage with NIH and FDA to Advance Research Posted on March 30, 2021 by Dezimey Kum - Blog Post
People of Color Continue to Be Underrepresented in Research on New Drugs Posted on March 9, 2021 by Sophie Kenward - Blog Post
Harnessing the Power of AI for All Patients Requires Focus on Equity and Transparency Posted on March 4, 2021 by Sophie Kenward - Blog Post
SWHR Applauds President Biden’s Appointment of Dr. Janet Woodcock as Acting Commissioner of the FDA Posted on February 18, 2021 by Sophie Kenward - Resource
SWHR Supports FDA Recommendations to Include Younger Women in Breast Cancer Research Posted on December 8, 2020 by Liz Hay - Resource
SWHR Comments to FDA on MDUFA Reauthorization for Fiscal Years 2023-2027 Posted on November 23, 2020 by Liz Hay - Resource
